KibimA Spanish startup that develops Amnesty International Models for Medical Photography, which extends on tumors, immunology, neuroscience, and metabolic disorders, A collection of 50 million dollars In the A series of financing.
Cash injection comes at a time when it makes artificial intelligence Drug detection For clinical experiences.
Quibim, for its part, enhances the accuracy of the diagnosis and the discovery of diseases from visual data purchased from X -rays, CT scans, and magnetic resonance. The pioneering product of the company, QP-prestateIt is designed to improve the detection of prostate cancer, with separate products brainand Liverand ReleaseAnd lung.
Separately, Quibim also offers QP Insights For multi -tool data processing (i.e. different types of biological data), for example in clinical trials and related studies.
QUIBIM says her long -term plan is to create Digital twins From the entire human body, “dynamic models” that help the medical community better understand the human body. Everything begins in the “level and pest level”, as shown by QP-PROSTATE.
Plan for growth in the United States
QUIBIM, which is based in Valencia, has collected about $ 70 million since its establishment, and with its latest funding, the company says it plans to reduce expansion plans in the United States. In fact, quibim FDA 510 (K) received clearance Once again in 2023 to market its respected product QP; also I rented the first Senior Medical officials in the United States
At the time of writing this report, Quibim says it has 170 world facilities, with partners including Stanford University and Harvard’s integrated health care system General Brigham group. Separately, Philips Plans announced in advance To integrate AI models into Quibim into light scanners.
The Quibim Tour of the series A. Spanish investment capital company Asabis And the private stock company BenavistaWith the participation of a large number of institutional and individual investors, including: Amadeus Capital Partners, Apex Ventures, Partec, iPod and iPhone, Tony Fadel.
“The QUIBIM mission is to convert photography into a stimulant for accuracy health,” CEO of Quibim and co -founder ángel alberich-bayarri He said in a statement. “Our global expansion in the United States is a decisive milestone, where we work with drug leaders and health care providers to cancel the security force insurance to revolutionize diagnoses and improve patients’ results.”
